Top

Published in:

Open Access 01-12-2022 | Thyroidectomy | Research

Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study

Authors: Jinkui Wang, Chenghao Zhanghuang, Liming Jin, Zhaoxia Zhang, Xiaojun Tan, Tao Mi, Jiayan Liu, Mujie Li, Xin Wu, Xiaomao Tian, Dawei He

Published in: BMC Geriatrics | Issue 1/2022

Abstract

Objective

Thyroid carcinoma (TC) is the most common endocrine tumor in the human body. Papillary thyroid carcinoma (PTC) accounts for more than 80% of thyroid cancers. Accurate prediction of elderly PTC can help reduce the mortality of patients. We aimed to construct a nomogram predicting cancer-specific survival (CSS) in elderly patients with PTC.

Methods

Patient information was downloaded from the Surveillance, Epidemiology, and End Results (SEER) program. Univariate and multivariate Cox regression models were used to screen the independent risk factors for patients with PTC. The nomogram of elderly patients with PTC was constructed based on the multivariate Cox regression model. We used the concordance index (C-index), the area under the receiver operating characteristic curve (AUC) and the calibration curve to test the accuracy and discrimination of the prediction model. Decision curve analysis (DCA) was used to test the clinical value of the model.

Results

A total of 14,138 elderly patients with PTC were included in this study. Patients from 2004 to 2015 were randomly divided into a training set (N = 7379) and a validation set (N = 3141), and data from 2016 to 2018 were divided into an external validation set (N = 3618). Proportional sub-distribution hazard model showed that age, sex, tumor size, histological grade, TNM stage, surgery and chemotherapy were independent risk factors for prognosis. In the training set, validation set and external validation set, the C-index was 0.87(95%CI: 0.852–0.888), 0.891(95%CI: 0.866–0.916) and 0.931(95%CI:0.894–0.968), respectively, indicating that the nomogram had good discrimination. Calibration curves and AUC suggest that the prediction model has good discrimination and accuracy.

Conclusions

We constructed a new nomogram to predict CSS in elderly patients with PTC. Internal cross-validation and external validation indicate that the model has good discrimination and accuracy. The predictive model can help doctors and patients make clinical decisions.

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660 (Epub 2021 Feb 4 PMID: 33538338).CrossRefPubMed

Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974–2013. JAMA. 2017;317(13):1338–48. https://doi.org/10.1001/jama.2017.2719.PMID:28362912;PMCID:PMC8216772.CrossRefPubMedPubMedCentral

Castagna MG, Cantara S, Pacini F. Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients. J Endocrinol Invest. 2016;39(10):1087–94. https://doi.org/10.1007/s40618-016-0503-z (Epub 2016 Jun 27 PMID: 27350556).CrossRefPubMed

Veiga LH, Neta G, Aschebrook-Kilfoy B, Ron E, Devesa SS. Thyroid cancer incidence patterns in Sao Paulo, Brazil, and the US SEER program, 1997–2008. Thyroid. 2013;23(6):748–57 (Epub 2013 May 28 PMID: 23410185; PMCID: PMC3675840).CrossRef

Wiltshire JJ, Drake TM, Uttley L, Balasubramanian SP. Systematic Review of Trends in the Incidence Rates of Thyroid Cancer. Thyroid. 2016;26(11):1541–52. https://doi.org/10.1089/thy.2016.0100 (PMID: 27571228).CrossRefPubMed

Adam MA, Thomas S, Hyslop T, Scheri RP, Roman SA, Sosa JA. Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems. J Clin Oncol. 2016;34(36):4415–20 (Epub 2016 Oct 28 PMID: 27998233; PMCID: PMC6366247).CrossRef

Wang F, Yu X, Shen X, Zhu G, Huang Y, Liu R, Viola D, Elisei R, Puxeddu E, Fugazzola L, Colombo C, Jarzab B, Czarniecka A, Lam AK, Mian C, Vianello F, Yip L, Riesco-Eizaguirre G, Santisteban P, O’Neill CJ, Sywak MS, Clifton-Bligh R, Bendlova B, Sýkorová V, Wang Y, Liu S, Zhao J, Zhao S, Xing M. The Prognostic Value of Tumor Multifocality in Clinical Outcomes of Papillary Thyroid Cancer. J Clin Endocrinol Metab. 2017;102(9):3241–50. https://doi.org/10.1210/jc.2017-00277.PMID:28582521;PMCID:PMC5587077.CrossRefPubMedPubMedCentral

Vaccarella S, Lortet-Tieulent J, Colombet M, Davies L, Stiller CA, Schüz J, Togawa K, Bray F, Franceschi S, Dal Maso L, Steliarova-Foucher E; IICC-3 contributors. Global patterns and trends in incidence and mortality of thyroid cancer in children and adolescents: a population-based study. Lancet Diabetes Endocrinol. 2021 Mar;9(3):144–152. doi: https://doi.org/10.1016/S2213-8587(20)30401-0. Epub 2021 Jan 19. PMID: 33482107.

Schneider DF, Chen H. New developments in the diagnosis and treatment of thyroid cancer. CA Cancer J Clin. 2013;63(6):374–94 (Epub 2013 Jun 24 PMID: 23797834; PMCID: PMC3800231).CrossRef

10.

van Gerwen M, Alpert N, Sinclair C, Kale M, Genden E, Taioli E. Assessing non-aggressiveness of untreated, local and regional, papillary thyroid cancer. Oral Oncol. 2020;105: 104674. https://doi.org/10.1016/j.oraloncology.2020.104674 (Epub 2020 Apr 9 PMID: 32279012).CrossRefPubMed

11.

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association Management Guidelines for Adult patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid. 2016;26(1):1–133. https://doi.org/10.1089/thy.2015.0020.PMID:26462967;PMCID:PMC4739132.CrossRefPubMedPubMedCentral

12.

Samra B, Jabbour E, Ravandi F, Kantarjian H, Short NJ. Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions. J Hematol Oncol. 2020;13(1):70. https://doi.org/10.1186/s13045-020-00905-2.PMID:32503572;PMCID:PMC7275444.CrossRefPubMedPubMedCentral

13.

Vini L, Hyer SL, Marshall J, A’Hern R, Harmer C. Long-term results in elderly patients with differentiated thyroid carcinoma. Cancer. 2003;97(11):2736–42. https://doi.org/10.1002/cncr.11410 (PMID: 12767085).CrossRefPubMed

14.

Banerjee M, Muenz DG, Chang JT, Papaleontiou M, Haymart MR. Tree-based model for thyroid cancer prognostication. J Clin Endocrinol Metab. 2014;99(10):3737–45 (Epub 2014 Jul 17 PMID: 25033070; PMCID: PMC4184064).CrossRef

15.

Park KS, Kim SH, Oh JH, Kim SY. Highly accurate diagnosis of papillary thyroid carcinomas based on personalized pathways coupled with machine learning. Brief Bioinform. 2021;22(4):bbaa336 (PMID: 33341874; PMCID: PMC8599295).CrossRef

16.

Lin Y, Lai S, Wang P, Li J, Chen Z, Wang L, Guan H, Kuang J. Performance of current ultrasound-based malignancy risk stratification systems for thyroid nodules in patients with follicular neoplasms. Eur Radiol. 2022;32(6):3617–30 (Epub 2022 Jan 1 PMID: 34973102; PMCID: PMC9122875).CrossRef

17.

Fullmer T, Cabanillas ME, Zafereo M. Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer. Front Endocrinol (Lausanne). 2021;15(12): 720723. https://doi.org/10.3389/fendo.2021.720723.PMID:34335481;PMCID:PMC8321684.CrossRef

18.

Park YH, Lee SJ, Cho EY, La Choi Y, Lee JE, Nam SJ, Yang JH, Shin JH, Ko EY, Han BK, Ahn JS, Im YH. Clinical relevance of TNM staging system according to breast cancer subtypes. Ann Oncol. 2019;30(12):2011. https://doi.org/10.1093/annonc/mdz223.Erratumfor:AnnOncol.2011Jul;22(7):1554-60 (PMID: 31408085).CrossRefPubMed

19.

Wang J, Zhanghuang C, Tan X, Mi T, Liu J, Jin L, Li M, Zhang Z, He D. Development and Validation of a Competitive Risk Model in Elderly Patients With Chromophobe Cell Renal Carcinoma: A Population-Based Study. Front Public Health. 2022;22(10): 840525. https://doi.org/10.3389/fpubh.2022.840525.PMID:35273943;PMCID:PMC8902051.CrossRef

20.

Allignol A, Beyersmann J. Software for fitting nonstandard proportional subdistribution hazards models. Biostatistics. 2010;11(4):674–5. https://doi.org/10.1093/biostatistics/kxq018 (Epub 2010 Mar 26 PMID: 20348397).CrossRefPubMed

21.

Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173–80. https://doi.org/10.1016/S1470-2045(14)71116-7.PMID:25846097;PMCID:PMC4465353.CrossRefPubMedPubMedCentral

22.

Hilden J. The area under the ROC curve and its competitors. Med Decis Making. 1991;11(2):95–101 (PMID: 1865785).CrossRef

23.

Wang S, Yang L, Ci B, Maclean M, Gerber DE, Xiao G, Xie Y. Development and Validation of a Nomogram Prognostic Model for SCLC Patients. J Thorac Oncol. 2018;13(9):1338–48 (Epub 2018 Jun 11 PMID: 29902534; PMCID: PMC7678404).CrossRef

24.

Tsalatsanis A, Hozo I, Vickers A, Djulbegovic B. A regret theory approach to decision curve analysis: a novel method for eliciting decision makers’ preferences and decision-making. BMC Med Inform Decis Mak. 2010;16(10):51. https://doi.org/10.1186/1472-6947-10-51.PMID:20846413;PMCID:PMC2954854.CrossRef

25.

Prete A, Borges de Souza P, Censi S, Muzza M, Nucci N, Sponziello M. Update on Fundamental Mechanisms of Thyroid Cancer. Front Endocrinol (Lausanne). 2020 Mar 13;11:102. doi: https://doi.org/10.3389/fendo.2020.00102. PMID: 32231639; PMCID: PMC7082927.

26.

Biliotti GC, Martini F, Vezzosi V, Seghi P, Tozzi F, Castagnoli A, Basili G, Peri A. Specific features of differentiated thyroid carcinoma in patients over 70 years of age. J Surg Oncol. 2006;93(3):194–8. https://doi.org/10.1002/jso.20512 (PMID: 16482598).CrossRefPubMed

27.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. https://doi.org/10.3322/caac.21551 (Epub 2019 Jan 8 PMID: 30620402).CrossRefPubMed

28.

Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D, Bray F. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403. https://doi.org/10.1016/j.ejca.2012.12.027 (Epub 2013 Feb 26 PMID: 23485231).CrossRefPubMed

29.

Park HS, Roman SA, Sosa JA. Treatment patterns of aging Americans with differentiated thyroid cancer. Cancer. 2010;116(1):20–30. https://doi.org/10.1002/cncr.24717 (PMID: 19908255).CrossRefPubMed

30.

Dellal FD, Özdemir D, Tam AA, Baser H, Tatli Dogan H, Parlak O, Ersoy R, Cakir B. Clinicopathological features of thyroid cancer in the elderly compared to younger counterparts: single-center experience. J Endocrinol Invest. 2017;40(5):471–9. https://doi.org/10.1007/s40618-016-0577-7 (Epub 2016 Nov 24 PMID: 27885512).CrossRefPubMed

31.

Santangelo G, Del Giudice S, Gallucci F, Parmeggiani U, De Falco M. Cancer of the thyroid gland in geriatric age: a single center retrospective study with a 10-year postoperative follow-up. Int J Surg. 2014;12(Suppl 2):S103–7. https://doi.org/10.1016/j.ijsu.2014.08.368 (Epub 2014 Aug 23 PMID: 25183645).CrossRefPubMed

32.

Karadaghy OA, Kallogjeri D, Piccirillo JF. Development of a New Clinical Severity Staging System for patients With Nonmetastatic Papillary Thyroid Carcinoma. JAMA Otolaryngol Head Neck Surg. 2017;143(12):1173–80. https://doi.org/10.1001/jamaoto.2017.0550.PMID:28449113;PMCID:PMC5824303.CrossRefPubMedPubMedCentral

33.

Ito Y, Miyauchi A, Oda H, Masuoka H, Higashiyama T, Kihara M, Miya A. Appropriateness of the revised Japanese guidelines’ risk classification for the prognosis of papillary thyroid carcinoma: a retrospective analysis of 5,845 papillary thyroid carcinoma patients. Endocr J. 2019;66(2):127–34. https://doi.org/10.1507/endocrj.EJ17-0061 (Epub 2019 Jan 9 PMID: 30626761).CrossRefPubMed

34.

Ho AS, Luu M, Zalt C, Morris LGT, Chen I, Melany M, Ali N, Patio C, Chen Y, Mallen St-Clair J, Braunstein GD, Sacks WL, Zumsteg ZS. Mortality Risk of Nonoperative Papillary Thyroid Carcinoma: A Corollary for Active Surveillance. Thyroid. 2019;29(10):1409–17 (Epub 2019 Sep 24 PMID: 31407637; PMCID: PMC7476400).CrossRef

35.

Jin LX, Moley JF. Surgery for lymph node metastases of medullary thyroid carcinoma: A review. Cancer. 2016;122(3):358–66. https://doi.org/10.1002/cncr.29761 (Epub 2015 Nov 5 PMID: 26539937).CrossRefPubMed

36.

Feng J, Gan X, Shen F, Cai W, Xu B. The role of two tumor foci for predicting central lymph node metastasis in papillary thyroid carcinoma: A meta-analysis. Int J Surg. 2018;52:166–70. https://doi.org/10.1016/j.ijsu.2018.02.029 (Epub 2018 Feb 23 PMID: 29481991).CrossRefPubMed

37.

Calò PG, Medas F, Loi G, Erdas E, Pisano G, Nicolosi A. Differentiated thyroid cancer in the elderly: our experience. Int J Surg. 2014;12(Suppl 2):S140–3. https://doi.org/10.1016/j.ijsu.2014.08.362 (Epub 2014 Aug 23 PMID: 25183640).CrossRefPubMed

38.

Nilubol N, Zhang L, Kebebew E. Multivariate analysis of the relationship between male sex, disease-specific survival, and features of tumor aggressiveness in thyroid cancer of follicular cell origin. Thyroid. 2013;23(6):695–702 (Epub 2013 May 28 PMID: 23194434; PMCID: PMC3675841).CrossRef

39.

Zhao L, Yan H, Pang P, Fan X, Jia X, Zang L, Luo Y, Wang F, Yang G, Gu W, Du J, Wang X, Lyu Z, Dou J, Mu Y. Thyroid nodule size calculated using ultrasound and gross pathology as predictors of cancer: A 23-year retrospective study. Diagn Cytopathol. 2019;47(3):187–93. https://doi.org/10.1002/dc.24068 (Epub 2018 Nov 29 PMID: 30499203).CrossRefPubMed

40.

Wang TS, Goffredo P, Sosa JA, Roman SA. Papillary thyroid microcarcinoma: an over-treated malignancy? World J Surg. 2014;38(9):2297–303. https://doi.org/10.1007/s00268-014-2602-3 (PMID: 24791670).CrossRefPubMed

41.

Cooper DS, Specker B, Ho M, Sperling M, Ladenson PW, Ross DS, Ain KB, Bigos ST, Brierley JD, Haugen BR, Klein I, Robbins J, Sherman SI, Taylor T, Maxon HR 3rd. Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry. Thyroid. 1998;8(9):737–44. https://doi.org/10.1089/thy.1998.8.737 (PMID: 9777742).CrossRefPubMed

42.

Tuttle RM, Fleisher M, Francis GL, Robbins RJ. Serum vascular endothelial growth factor levels are elevated in metastatic differentiated thyroid cancer but not increased by short-term TSH stimulation. J Clin Endocrinol Metab. 2002;87(4):1737–42. https://doi.org/10.1210/jcem.87.4.8388 (PMID: 11932308).CrossRefPubMed

43.

Carhill AA, Litofsky DR, Ross DS, Jonklaas J, Cooper DS, Brierley JD, Ladenson PW, Ain KB, Fein HG, Haugen BR, Magner J, Skarulis MC, Steward DL, Xing M, Maxon HR, Sherman SI. Long-Term Outcomes Following Therapy in Differentiated Thyroid Carcinoma: NTCTCS Registry Analysis 1987–2012. J Clin Endocrinol Metab. 2015;100(9):3270–9 (Epub 2015 Jul 14 PMID: 26171797; PMCID: PMC5393522).CrossRef

44.

Flynn RW, Bonellie SR, Jung RT, MacDonald TM, Morris AD, Leese GP. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab. 2010;95(1):186–93. https://doi.org/10.1210/jc.2009-1625 (Epub 2009 Nov 11 PMID: 19906785).CrossRefPubMed

45.

Tuttle RM, Ahuja S, Avram AM, Bernet VJ, Bourguet P, Daniels GH, Dillehay G, Draganescu C, Flux G, Führer D, Giovanella L, Greenspan B, Luster M, Muylle K, Smit JWA, Van Nostrand D, Verburg FA, Hegedüs L. Controversies, Consensus, and Collaboration in the Use of 131I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association. Thyroid. 2019;29(4):461–70. https://doi.org/10.1089/thy.2018.0597 (PMID: 30900516).CrossRefPubMed

46.

Turrentine FE, Wang H, Simpson VB, Jones RS. Surgical risk factors, morbidity, and mortality in elderly patients. J Am Coll Surg. 2006;203(6):865–77. https://doi.org/10.1016/j.jamcollsurg.2006.08.026 (PMID: 17116555).CrossRefPubMed

47.

Korc-Grodzicki B, Downey RJ, Shahrokni A, Kingham TP, Patel SG, Audisio RA. Surgical considerations in older adults with cancer. J Clin Oncol. 2014;32(24):2647–53. https://doi.org/10.1200/JCO.2014.55.0962 (Epub 2014 Jul 28 PMID: 25071124).CrossRefPubMed

48.

Zhou J, Tan J, Ming J, Guo H, Li X, Zhang N, Huang T. Management of Very Elderly patients With Papillary Thyroid Cancer: Analysis of Outcomes for Surgery Versus Nonsurgery. J Surg Res. 2020;256:512–9. https://doi.org/10.1016/j.jss.2020.07.017 (Epub 2020 Aug 13 PMID: 32798999).CrossRefPubMed

Title: Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study
Authors: Jinkui Wang
Chenghao Zhanghuang
Liming Jin
Zhaoxia Zhang
Xiaojun Tan
Tao Mi
Jiayan Liu
Mujie Li
Xin Wu
Xiaomao Tian
Dawei He
Publication date: 01-12-2022
Publisher: BioMed Central
Keywords: Thyroidectomy
Thyroidectomy
Thyroid Cancer
Thyroid Cancer
Thyroid Cancer
Published in: BMC Geriatrics / Issue 1/2022
Electronic ISSN: 1471-2318
DOI: https://doi.org/10.1186/s12877-022-03430-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2022

The feasibility and reliability of measuring forearm muscle thickness by ultrasound in a geriatric inpatient setting: a cross-sectional pilot study

Application of machine learning model to predict lacunar cerebral infarction in elderly patients with femoral neck fracture before surgery

Efficacy and acceptability of using wearable activity trackers in older adults living in retirement communities: a mixed method study

Regional differences regarding the occurrence of falls and associated factors in two populations of Brazilian longevous people

Lower body muscle strength, dynapenic obesity and risk of type 2 diabetes –longitudinal results on the chair-stand test from the Survey of Health, Ageing and Retirement in Europe (SHARE)

Specific lysophosphatidylcholine and acylcarnitine related to sarcopenia and its components in older men

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials